Physician profile
Brian M Scholl
NPI 1801857032
$90,706.89
in general payments reported to CMS, 2019-2025
12 companies · $22K in 2025
The $22K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $2,580 · 2021: $17K · 2022: $20K · 2023: $251 · 2024: $15K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $36K · Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $36,008.55 |
| Food and Beverage | $493.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirus, LLC | $73,550.77 | 2019-2025 | Europa Pedicle Screw System |
| Medtronic USA, INC. | $8,414.99 | 2019-2020 | |
| Curiteva, INC. | $5,928.43 | 2019-2025 | |
| Medtronic, INC. | $1,660.82 | 2021-2025 | Aquamantys(Tm), Inceptiv |
| Alphatec Spine, INC | $472.08 | 2021-2022 | |
| Si-Bone, INC. | $369.01 | 2020-2024 | |
| Abbott Laboratories | $160.42 | 2022-2025 | Proclaim |
| Globus Medical, INC. | $70.22 | 2025 | Senza |
| Prime Surgical, LLC | $24.26 | 2025 | |
| Ethicon US, LLC | $22.20 | 2023 | Surgiflo Hemostatic Matrix, Vistaseal, Evarrest |
| Baxter Healthcare | $18.15 | 2023 | Floseal |
| Orthofix Medical, INC. | $15.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Scholl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.